News

NewAmsterdam Pharma Set for Key Presentations and Events in September

NewAmsterdam Pharma Set for Key Presentations and Events in September

NewAmsterdam Pharma's Upcoming Events and Presentations

NAARDEN and MIAMI — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS), a leader in biopharmaceutical innovations, is gearing up for a series of significant events in the coming weeks. This late-stage clinical biopharmaceutical firm is dedicated to developing oral, non-statin medications aimed at patients facing cardiovascular disease (CVD) risks due to elevated low-density lipoprotein cholesterol (LDL-C). Unfortunately, current treatment options often fall short for these individuals. To address this, NewAmsterdam will share pivotal findings on their investigational treatments at key industry gatherings.

European Society of Cardiology Congress

This year, NewAmsterdam will present at the esteemed European Society of Cardiology Congress (ESC), scheduled from August 29 to September 1. This Congress serves as a prominent platform for cardiology professionals worldwide, offering insights into cutting-edge research and treatments. NewAmsterdam will highlight pooled safety and efficacy data from the Phase 3 BROADWAY and BROOKLYN trials.

Presentation Details

One of the key presentations will be on the efficacy of obicetrapib across various lipid-lowering therapies based on the Broadway and Brooklyn randomized trials. Dr. Kausik Ray will present this enlightening session titled "Changing Face of Lipid-Lowering Therapy" on August 29 at 10:10 AM CEST. Additionally, Dr. Stephen Nicholls will discuss the impact of obicetrapib on cardiovascular events during the "Late-Breaking Clinical Science" session on September 1 at 9:00 AM CEST.

Participation in Investor Conferences

Aside from the ESC, NewAmsterdam will also engage actively in several crucial investor conferences during the same time frame. One highlighted event is Citi's 2025 Biopharma Back to School Summit on September 3, where CEO Michael Davidson and CFO Ian Somaiya will participate in a fireside chat at 2:30 PM ET in Boston.

Other Notable Conferences

NewAmsterdam will continue its conference schedule with the Cantor Global Healthcare Conference on September 4, presenting again with Dr. Davidson and Mr. Somaiya at 2:45 PM ET in New York. Finally, the company will conclude their participation in this series with the Wells Fargo Healthcare Conference on September 5, showcasing insights from CFO Ian Somaiya at 10:15 AM ET in Boston.

Webcast Availability

For those unable to attend, live webcasts of these presentations will be accessible via the investor relations section of the NewAmsterdam Pharma website. Following these live events, recorded sessions will also be made available for later viewing, ensuring that stakeholders stay informed of the latest developments.

About NewAmsterdam Pharma

NewAmsterdam Pharma (Nasdaq: NAMS) is committed to enhancing patient outcomes for metabolic diseases, particularly in populations with unmet medical needs. The company is focused on ensuring patients have access to safe and effective therapies that significantly lower LDL levels while being well-tolerated. NewAmsterdam is striving to broaden the therapeutic options by utilizing obicetrapib—a once-daily CETP inhibitor—to enhance LDL-C reduction, especially in patients already on statin therapies who are often underserved by existing treatments.

Company Contact Information

Matthew Philippe
P: 1-917-882-7512
Email: matthew.philippe@newamsterdampharma.com

Frequently Asked Questions

What is the purpose of NewAmsterdam Pharma's upcoming presentations?

The presentations aim to showcase new data from their clinical trials on LDL-C treatments, which could significantly impact cardiology practices.

When and where will the European Society of Cardiology Congress take place?

The Congress is set for August 29 to September 1 in Madrid, serving as a significant platform for health professionals in cardiology.

Who will represent NewAmsterdam Pharma at the investor conferences?

CEO Michael Davidson and CFO Ian Somaiya will be key presenters at multiple investor events, engaging with industry stakeholders.

Will the presentations be available for later viewing?

Yes, live webcasts will be provided and recordings will be accessible for those who cannot attend the live sessions.

What is NewAmsterdam Pharma's core mission?

The company aims to innovate safe and effective treatments for metabolic diseases, particularly for patients at risk of cardiovascular complications.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 0

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 7

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 5

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Crawford Nickel Project Advances Under Ontario's New Framework

Updated Category News Views 90

Introduction to the Crawford Nickel Project Canada Nickel Company Inc. has exciting news regarding its Crawford Nickel Project, which has been officially recognized by the Province of Ontario. This milestone comes as part of Ontario's One Project, One Process (1P1P) framework, a major step forward for the mining sector. Understanding the One Project, One Process Framework...

Continue Reading
TeamBridge Secures $28 Million to Enhance Workforce Technology

Updated Category News Views 124

TeamBridge Secures $28 Million to Revolutionize the Hourly Workforce TeamBridge, a rapidly expanding Workforce Operating System (Workforce OS), has successfully raised $28 million in Series B funding. This round was led by Mayfield, with considerable backing from existing investors, including General Catalyst and Abstract Ventures. This funding represents a significant...

Continue Reading
Innovative AI Collaboration for Breakthrough Cancer Therapies

Updated Category News Views 116

Pierre Fabre Laboratories and Iktos Unite for Oncology Drug Discovery Pierre Fabre Laboratories and Iktos have announced an exciting new collaboration aimed at transforming drug discovery in oncology. This partnership harnesses the strengths of both companies to utilize advanced AI technologies for developing new small-molecule drug candidates. Together, they plan to make...

Continue Reading
Vitamin Angels Partners with Walgreens to Improve Lives Globally

Updated Category News Views 529

Vitamin Angels and Walgreens: A Transformative Partnership Vitamin Angels and Walgreens have reached a remarkable achievement, positively impacting the lives of 500 million women and children across the globe. Over the course of their partnership, they have dedicated themselves to providing essential vitamins and minerals primarily to underserved communities within the...

Continue Reading
Forecasting the Growth of India's Flourishing Fluoropolymer Market

Updated Category News Views 104

Understanding the Flourishing Fluoropolymer Market in India India's fluoropolymer market is on an impressive trajectory, forecasted to reach a valuation of US$ 799.28 million by 2033 from US$ 425.12 million in 2024, reflecting an annual growth rate (CAGR) of 7.46% during the years ahead. This surge can be attributed to various factors, including technological...

Continue Reading